Immunovant Inc’s recently made public that its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $0.1 million on Aug 21 ’24. In the deal valued at $31.86 per share,3,295 shares were sold. As a result of this transaction, Levine Mark S. now holds 330,099 shares worth roughly $9.7 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Macias William L. sold 3,027 shares, generating $96,437 in total proceeds. Upon selling the shares at $31.86, the Chief Medical Officer now owns 368,332 shares.
Before that, Barnett Eva Renee sold 3,768 shares. Immunovant Inc shares valued at $120,045 were divested by the Chief Financial Officer at a price of $31.86 per share. As a result of the transaction, Barnett Eva Renee now holds 343,776 shares, worth roughly $10.11 million.
Oppenheimer initiated its Immunovant Inc [IMVT] rating to an Outperform in a research note published on March 28, 2024; the price target was $50. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering IMVT with “an Overweight” recommendation on February 20, 2024. Wolfe Research started covering the stock on February 15, 2024. It rated IMVT as “an Outperform”.
Price Performance Review of IMVT
On Monday, Immunovant Inc [NASDAQ:IMVT] saw its stock fall -3.64% to $29.40. Over the last five days, the stock has gained 3.12%. Immunovant Inc shares have fallen nearly -30.22% since the year began. Nevertheless, the stocks have fallen -19.69% over the past one year. While a 52-week high of $45.58 was reached on 01/09/24, a 52-week low of $24.67 was recorded on 06/10/24. SMA at 50 days reached $29.81, while 200 days put it at $31.71.
Levels Of Support And Resistance For IMVT Stock
The 24-hour chart illustrates a support level at 28.69, which if violated will result in even more drops to 27.97. On the upside, there is a resistance level at 30.35. A further resistance level may holdings at 31.29. The Relative Strength Index (RSI) on the 14-day chart is 49.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.31%. Stochastics %K at 72.92% indicates the stock is a holding.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2024-09-13, growing by 0.23 million shares to a total of 12.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 12.23 million shares. There was a rise of 1.83%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 12, 2023 when Deutsche Bank began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
